| Toll-like receptor 9 activation: a novel mechanism linking placenta-derived mitochondrial DNA and vascular dysfunction in pre-eclampsia. | |
| | |
MedLine Citation:
|
PMID: 22671429 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Emerging evidence suggests that in addition to being the 'power houses' of our cells, mitochondria facilitate effector responses of the immune system. Cell death and injury result in the release of mtDNA (mitochondrial DNA) that acts via TLR9 (Toll-like receptor 9), a pattern recognition receptor of the immune system which detects bacterial and viral DNA but not vertebrate DNA. The ability of mtDNA to activate TLR9 in a similar fashion to bacterial DNA stems from evolutionarily conserved similarities between bacteria and mitochondria. mtDNA may be the trigger of systemic inflammation in pathologies associated with abnormal cell death. PE (pre-eclampsia) is a hypertensive disorder of pregnancy with devastating maternal and fetal consequences. The aetiology of PE is unknown and removal of the placenta is the only effective cure. Placentas from women with PE show exaggerated necrosis of trophoblast cells, and circulating levels of mtDNA are higher in pregnancies with PE. Accordingly, we propose the hypothesis that exaggerated necrosis of trophoblast cells results in the release of mtDNA, which stimulates TLR9 to mount an immune response and to produce systemic maternal inflammation and vascular dysfunction that lead to hypertension and IUGR (intra-uterine growth restriction). The proposed hypothesis implicates mtDNA in the development of PE via activation of the immune system and may have important preventative and therapeutic implications, because circulating mtDNA may be potential markers of early detection of PE, and anti-TLR9 treatments may be promising in the management of the disease. |
| | |
Authors:
|
Styliani Goulopoulou; Takayuki Matsumoto; Gisele F Bomfim; R Clinton Webb |
Related Documents
:
|
22403589 - Cellular networks controlling th2 polarization in allergy and immunity. 22665379 - Immune-activating properties of panton-valentine leukocidin improve the outcome in a mo... 22355009 - Braf(v600) inhibitor gsk2118436 targeted inhibition of mutant braf in cancer patients d... 20591509 - Mechanisms of peripheral immune-cell-mediated analgesia in inflammation: clinical and t... 22505709 - P38 mitogen-activated protein kinase and nuclear factor-κb facilitate cd40-mediated sa... 22316559 - Immunomodulation of microglia by docosahexaenoic acid and eicosapentaenoic acid. 20561139 - The evolution of host-specific variation in cuckoo eggshell strength. 15489189 - Ifn-inducible gtpases and immunity to intracellular pathogens. 20483789 - Arginase i suppresses il-12/il-23p40-driven intestinal inflammation during acute schist... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical science (London, England : 1979) Volume: 123 ISSN: 1470-8736 ISO Abbreviation: Clin. Sci. Publication Date: 2012 Oct |
Date Detail:
|
Created Date: 2012-06-07 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7905731 Medline TA: Clin Sci (Lond) Country: England |
Other Details:
|
Languages: eng Pagination: 429-35 Citation Subset: IM |
Affiliation:
|
*Department of Physiology, Georgia Health Sciences University, Augusta, GA, U.S.A. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Magnesium and its transporters in cancer: a novel paradigm in tumour development.
Next Document: Chiral Phosphoric Acid Catalyzed Inverse-Electron-Demand Aza-Diels-Alder Reaction of Isoeugenol Deri...